Stock·NASDAQ·Technology
Pagaya Technologies Ltd. Class A (PGY)
- Market cap
- $1.47B
- P/E
- 10.42
- Dividend yield
- No dividend
- Street target
- $27.00median of 11 analysts
- 52-week range
- $10.40 $29.75
PGY stock forecast today
Where PGY stands today, and what CleaRank Financial AI makes of it.
PGY at a glance
Pagaya Technologies Ltd. Class A (PGY): Buy, 66/100 on CleaRank's AI score.
- Trend Mixed: the price is above its 200-day but below its 50-day moving average ($16.38 and $19.32).
- Earnings PGY beat estimates in 6 of its last 7 quarters, yet fell in the first session after 3 of those beats.
- Insiders Insiders sold $19.7M and bought $501K over the last 18 months.
- Valuation P/E of 10.4 against 35.1 for the Technology sector: a discount to peers (-70%).
Figures as of November 6, 2026.
CleaRank Financial AI
PGY carries a CleaRank rating of Buy and a model score of 66/100.
Analysts' views do the most to lift that score, with 11 of 11 rating the shares a buy and a median target 54.3% above the price. The trend is mixed, since PGY is 9.42% below its 50-day average of $19.32 but 6.82% above its 200-day average of $16.38. Looking back over the past year, the price fell 25.18%.
Only on CleaRank
Figures we compute ourselves from PGY's own price, earnings and insider-filing history. Tap one to see it in context.
PGY stock price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
2/4Price below its 50-day average ›
The price of $17.50 is 9.4% below the 50-day simple moving average of $19.32.Price above its 200-day average ›
The price is 6.8% above the 200-day simple moving average of $16.38.50-day average above the 200-day ›
The 50-day average ($19.32) is 17.9% above the 200-day average ($16.38), the arrangement of a rising longer-term trend.In the lower half of its 52-week range ›
The price sits at 37% of its 52-week range, between $10.40 and $29.75.
PGY share price
Pick a period: each tab shows how far PGY has moved over it, to the last close.
Today's trading
Where PGY sits inside today's range and its 52-week range.
PGY fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
4/4P/E below the sector median ›
The trailing P/E of 10.42 is 70.3% below the Technology median of 35.1.P/S below the sector median ›
The price-to-sales ratio of 1.03 is 86.5% below the sector median of 7.6.Profitable over the last 12 months ›
Net income over the last 12 months was $149.9M on revenue of $1.4B, a net margin of 10.5%.Beat estimates in most recent reports ›
PGY beat the EPS estimate in 6 of its last 7 reports.
Key statistics
The headline figures for PGY.
As of November 6, 2026, PGY trades at $17.50, with a market value of $1.47B and a P/E ratio of 10.42.
What the numbers say
CleaRank Financial AI's reading of PGY's valuation, growth and risks.
On earnings, Pagaya Technologies Ltd. Class A (PGY) is valued at 10.42 times, against a median of 35.1 for Technology: a discount to peers, with the P/E 70.3% below that median. PGY trades at 1.03 times its sales, 86.4% below the sector median of 7.6. The company has a market capitalisation of $1.5B and trailing earnings of $1.68 a share.
Profitability shows a net margin of 10.5% and an operating margin of 28.82%, with a return on equity of 22.18%, above the sector median of 13.4%. The balance sheet rounds out the picture, with debt-to-equity of 1.42.
EPS of $1.07 against an estimate of $1.00 made the October 29, 2026 report a beat of 7.00%. The market reacted the other way, with the stock falling 7.59% in the first session after the report.
The earnings record shows 6 beats in 7 reports, though the stock still fell in the first session after 3 of those 6 beats. The consensus EPS estimate stands at $3.80 for this fiscal year and $4.17 for next, growth of 14.7% for the current year.
Day-to-day volatility is the first thing to plan around: PGY has moved 3.94% on a typical session. The price is 41.18% below its 52-week high of $29.75. Insiders sold $19.7M over the last 18 months and bought $501K, though sales of this kind are often planned in advance and say less than purchases would.
PGY against the Technology sector
How PGY compares with the median Technology stock CleaRank tracks.
Price to earnings vs sector: PGY trades at a notable discount to sector peers (-70% against the sector median P/E). Investors are paying less for each dollar of earnings than for the typical stock in the sector.
Return vs XLK: Since May 28, 2025, PGY has gained 2.3% against a gain of 42.5% for XLK.
Performance against XLK
PGY and the Technology sector fund over the same days.
Revenue and earnings
How much PGY sells, and how much of it becomes profit.
The quarterly bars end with Q2 '26 (the quarter to June 30, 2026); PGY reported again on October 29, 2026, and that quarter is not in our statement data yet. The 12-month figures come from the statistics feed and may include it.
Revenue growth: Revenue grew 25.6% in FY2025 to $1.3B, from $1.0B a year earlier.
Profit margin: The net margin was 5.7% in FY2025, up from -44.4% the year before.
Profitable: PGY earned $71.4M in FY2025.
Earnings reality check
Did PGY beat what analysts expected, and how did the stock react?
Earnings record: PGY beat the analyst estimate in 6 of the last 7 quarters.
Market reaction: The stock fell in the first session after 3 of those 6 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Oct 29, 2026 | $1.00 | $1.07 | +7.00% | -7.59% | -16.34% |
| Jul 30, 2026 | $0.72 | $1.07 | +48.61% | +9.24% | +21.43% |
| May 7, 2026 | $0.56 | $0.73 | +30.36% | -2.00% | -12.26% |
| Feb 9, 2026 | $0.77 | $0.80 | +3.90% | -3.59% | -13.32% |
| Nov 10, 2025 | $0.66 | $1.02 | +54.55% | +0.69% | -19.14% |
| Aug 7, 2025 | $0.67 | $0.64 | -4.48% | -6.37% | +9.47% |
| May 7, 2025 | $0.46 | $0.69 | +50.00% | +23.29% | +33.87% |
As of November 6, 2026, PGY has beaten the analyst EPS estimate in 6 of its last 7 reported quarters and fell in the first trading session after 3 of those beats; its latest report, on October 29, 2026, came in 7.00% above the estimate and the stock moved -7.59% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
PGY AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
1/3RSI not overbought or oversold ›
The 14-day RSI is 43.4, in neutral territory.RSI below 50 ›
An RSI of 43.4 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line below zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank Financial AI analysis of PGY
The score, the reasoning behind it, and what could move the price next.
PGY presents a mixed trend picture. Trading at $17.50, the stock sits 9.42% below its 50-day average of $19.32, yet it is 6.82% above its 200-day average of $16.38. Across its 52-week range of $10.40 to $29.75, the price stands at 37%, which leaves it 41.18% below the high.
The price is down over each of these periods: 3.53% over the past month, 17.76% over the past three months and 25.18% over the past year. The 14-day RSI of 43.4 is in the neutral zone, and the MACD line is negative.
Rating reaffirmed ›
TD Cowen kept its Buy rating on October 30, 2026.
Source: Analyst action, TD Cowen, October 30, 2026
Earnings beat, but the stock fell ›
The October 29, 2026 report beat the EPS estimate by 7.00%, and the share price fell 7.59% in the first session after it.
Source: Earnings report, October 29, 2026
- Keep an eye on the two closest levels: the 20-day EMA at $18.59 sits above the price, and the 200-day SMA at $16.38 sits below it.
- The 14-day RSI reads 43.4, in the neutral zone, with the MACD line negative; readings above 70 or below 30 mark stretched momentum.
- The share price fell 7.59% in the first session after the October 29, 2026 report. Over the last 7 reports, PGY beat estimates in 6.
The trend is mixed: PGY is above its 200-day average at $16.38 but below its 50-day average at $19.32. A close above the 50-day would turn both signals up, and a close below the 200-day would turn both down. The nearest levels are the 200-day SMA at $16.38 below and the 20-day EMA at $18.59 above.
Technical indicators
Momentum and trend for PGY, from its daily closes.
As of November 6, 2026, with PGY at $17.50, its 14-day RSI is 43.4 (neutral territory), its 50-day simple moving average is $19.32 and its 200-day is $16.38.
Calculated by CleaRank on daily closes as of November 6, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What PGY moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of November 6, 2026, PGY's 1-year correlation of daily returns is +0.47 with S&P 500 (SPY), +0.45 with Nasdaq 100 (QQQ), +0.38 with Bitcoin (BTC) and +0.04 with gold (XAU).
PGY price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
2/3Most analysts rate it a buy ›
11 of 11 analysts rate it a buy or strong buy, 0 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $27.00 is 54.3% above the price.Buy share not up from three months ago ›
11 of 11 rate it a buy now, against 10 of 10 three months ago.
PGY Wall Street View
12-month price targets
The price, $17.50, sits below every analyst's target.
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 30, 2026 | TD Cowen | Maintains | Buy |
| Oct 30, 2026 | B. Riley Securities | Reiterates | Buy |
| Oct 6, 2026 | TD Cowen | Maintains | Buy |
| Sep 29, 2026 | StoneX | Reiterates | Buy |
| Aug 18, 2026 | Jefferies | Maintains | Buy |
| Jul 31, 2026 | B. Riley Securities | Maintains | Buy |
As of November 6, 2026, 11 Wall Street analysts cover PGY: 11 rate it a buy or strong buy, 0 a hold and 0 a sell or strong sell. Their 12-month price targets range from $23.00 to $38.00. The median PGY price target is $27.00, 54.3% above the price of $17.50.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
PGY risk and volatility
How much it moves day to day, and how it stacks up against similar assets.
Risk profile
How much PGY tends to move, against the market and on its own.
PGY price history and drawdowns
PGY's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
0/4Typical daily move of 2% or more ›
A typical daily move is 3.94% (the standard deviation of the last 30 daily returns).Not yet recovered from its worst fall ›
The worst fall was 97.8%, from August 2022 to December 2022; the price is still 95.1% below that peak.Half or fewer of 1-year holds ended higher ›
38% of 1-year holding periods in the last 6 years ended with a gain.Trailed the S&P 500 since May 2021 ›
$10,000 invested in May 2021 is now worth $1,499, against $18,916 in the S&P 500 (SPY).
PGY Drawdowns & Recovery
As of November 6, 2026, PGY's worst peak-to-trough fall over the period since May 2021 was -97.8% (August 2022 to December 2022); it is still 95.1% below that peak, and 38% of 1-year holding periods ended with a gain.
From weekly closing values. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into PGY in May 2021 is worth now, against the same amount in the S&P 500.
Against the market: PGY trailed the S&P 500 over this period: $1,498.80 against $18,916.
A $10,000 investment in PGY in May 2021 would be worth about $1,499 today, compared with about $18,916 for the same investment in the S&P 500 benchmark with its dividends reinvested.
Seasonal patterns
Which calendar months have been kind to PGY, and which have not.
Strongest month, July: an average of +54.84%, up in 5 of 6 years.
Weakest month, September: an average of -22.03%, up in 2 of 6 years.
This month, November: has averaged -7.67%, up in 1 of 5 years. Past seasonality does not repeat on schedule.
Across 6 calendar years of history, PGY's strongest calendar month has been July (average +54.84%, up in 5 of 6 years) and its weakest September (average -22.03%, up in 2 of 6 years).
Average return for each calendar month across 6 calendar years of history, from weekly closing prices.
PGY stock price prediction 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in PGY, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 6 years of price history, projects that a $10,000 investment in PGY today could fall to about $6,558 by 2030 in the base case, with a 90th-percentile outcome near $23,623 and a 10th-percentile outcome around $1,820. Projections are statistical simulations, not guarantees.
PGY Stock Price Prediction 2030: Simulated Scenarios
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $11.48 for PGY by 2030 in the base case, from $17.50 today (0.7x over 4 years). The 10th-percentile path ends near $3.19. These are outcomes of a Monte Carlo simulation run on PGY's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $8.30 | $15.75 | $29.89 | |
| 2028 | $5.73 | $14.17 | $35.07 | |
| 2029 | $4.20 | $12.75 | $38.69 | |
| 2030 | $3.19 | $11.48 | $41.34 |
Method: a lognormal simulation of PGY's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. How the simulation works
PGY insider trading
What the people running the company have bought and sold.
PGY insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Net insider selling: Insiders bought $501K on the open market and sold $19.7M.
As of November 6, 2026, PGY insiders reported 56 open-market sales worth $19.7M and 2 open-market purchases worth $501K over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Oct 19, 2026 | Tami Rosen
Director
|
Option | 9.4K | $100.0K |
| Oct 2, 2026 | Tami Rosen
Director
|
Sell | 2.0K | $35.4K |
| Sep 28, 2026 | Sanjiv Das
President
|
Sell | 14.3K | $243.7K |
| Sep 28, 2026 | Cory Vieira
Officer
|
Sell | 2.2K | $37.0K |
| Sep 28, 2026 | Jonathan Dobres
Chief Financial Officer
|
Sell | 590 | $10.1K |
| Sep 25, 2026 | Sanjiv Das
President
|
Grant | 25.0K | - |
| Sep 25, 2026 | Jonathan Dobres
Chief Financial Officer
|
Grant | 1.1K | - |
| Sep 25, 2026 | Cory Vieira
Officer
|
Grant | 3.6K | - |
| Sep 17, 2026 | Jonathan Dobres
Chief Financial Officer
|
Sell | 2.2K | $45.9K |
| Sep 15, 2026 | Jonathan Dobres
Chief Financial Officer
|
Grant | 4.4K | - |
| Sep 11, 2026 | Sanjiv Das
President
|
Sell | 13.3K | $268.8K |
| Sep 11, 2026 | Tami Rosen
Director
|
Sell | 7.1K | $143.9K |
| Sep 11, 2026 | Jonathan Dobres
Chief Financial Officer
|
Sell | 985 | $18.0K |
| Sep 11, 2026 | Sanjiv Das
President
|
Grant | 23.8K | - |
| Sep 11, 2026 | Jonathan Dobres
Chief Financial Officer
|
Grant | 2.2K | - |
| Sep 11, 2026 | Tami Rosen
Director
|
Grant | 15.6K | - |
| Sep 3, 2026 | Tami Rosen
Director
|
Sell | 1.3K | $29.2K |
| Sep 2, 2026 | Cory Vieira
Officer
|
Sell | 3.1K | $69.8K |
| Sep 2, 2026 | Cory Vieira
Officer
|
Grant | 5.2K | - |
| Sep 1, 2026 | Jason M Gardner, PH.D.
Director
|
Grant | 5.9K | - |
| Aug 3, 2026 | Tami Rosen
Director
|
Sell | 28.2K | $619.4K |
| Aug 3, 2026 | Sanjiv Das
President
|
Sell | 21.3K | $468.4K |
| Aug 3, 2026 | Tami Rosen
Director
|
Grant | 7.3K | - |
| Jun 25, 2026 | Sanjiv Das
President
|
Sell | 14.0K | $221.6K |
| Jun 25, 2026 | Cory Vieira
Officer
|
Sell | 1.5K | $23.1K |
| Jun 25, 2026 | Sanjiv Das
President
|
Grant | 25.0K | - |
| Jun 25, 2026 | Cory Vieira
Officer
|
Grant | 3.6K | - |
| Jun 24, 2026 | Gal Krubiner
Chief Executive Officer
|
Buy | 16.2K | $250.5K |
| Jun 22, 2026 | Tami Rosen
Director
|
Sell | 9.9K | $151.1K |
| Jun 12, 2026 | Sanjiv Das
President
|
Sell | 13.3K | $216.0K |
| Jun 12, 2026 | Evangelos Perros
Former
|
Sell | 11.6K | $187.6K |
| Jun 12, 2026 | Tami Rosen
Director
|
Sell | 5.7K | $92.2K |
| Jun 12, 2026 | Sanjiv Das
President
|
Grant | 23.8K | - |
| Jun 12, 2026 | Evangelos Perros
Former
|
Grant | 20.6K | - |
| Jun 12, 2026 | Tami Rosen
Director
|
Grant | 15.6K | - |
| Jun 2, 2026 | Cory Vieira
Officer
|
Sell | 2.1K | $32.1K |
| Jun 2, 2026 | Gal Krubiner
Chief Executive Officer
|
Buy | 16.6K | $250.6K |
| Jun 2, 2026 | Cory Vieira
Officer
|
Grant | 5.2K | - |
| Apr 17, 2026 | Tami Rosen
Director
|
Sell | 9.7K | $147.2K |
| Apr 1, 2026 | Evangelos Perros
Chief Financial Officer
|
Sell | 13.0K | $147.5K |
| Apr 1, 2026 | Evangelos Perros
Chief Financial Officer
|
Grant | 22.8K | - |
| Mar 12, 2026 | Sanjiv Das
President
|
Sell | 9.7K | $106.6K |
| Mar 12, 2026 | Evangelos Perros
Chief Financial Officer
|
Sell | 8.4K | $92.6K |
| Mar 12, 2026 | Tami Rosen
Officer and Director
|
Sell | 5.9K | $64.9K |
| Mar 12, 2026 | Sanjiv Das
President
|
Grant | 23.8K | - |
| Mar 12, 2026 | Evangelos Perros
Chief Financial Officer
|
Grant | 20.6K | - |
| Mar 12, 2026 | Tami Rosen
Officer and Director
|
Grant | 15.6K | - |
| Mar 2, 2026 | Cory Vieira
Officer
|
Sell | 2.5K | $27.2K |
| Mar 2, 2026 | Cory Vieira
Officer
|
Grant | 5.2K | - |
| Jan 5, 2026 | Evangelos Perros
Chief Financial Officer
|
Sell | 9.8K | $224.2K |
| Jan 5, 2026 | Sanjiv Das
President
|
Sell | 3.9K | $90.7K |
| Dec 31, 2025 | Sanjiv Das
President
|
Grant | 8 | - |
| Dec 31, 2025 | Evangelos Perros
Chief Financial Officer
|
Grant | 22.8K | - |
| Dec 19, 2025 | Tami Rosen
Officer and Director
|
Sell | 7.6K | $172.8K |
| Dec 12, 2025 | Evangelos Perros
Chief Financial Officer
|
Sell | 11.6K | $259.1K |
| Dec 12, 2025 | Tami Rosen
Officer and Director
|
Sell | 8.1K | $180.2K |
| Dec 12, 2025 | Sanjiv Das
President
|
Sell | 568 | $12.7K |
| Dec 12, 2025 | Sanjiv Das
President
|
Grant | 23.8K | - |
| Dec 12, 2025 | Evangelos Perros
Chief Financial Officer
|
Grant | 20.6K | - |
| Dec 12, 2025 | Tami Rosen
Officer and Director
|
Grant | 15.6K | - |
| Dec 10, 2025 | Alison Davis
Director
|
Grant | 11.4K | - |
| Dec 10, 2025 | Harvey Golub
Director
|
Grant | 11.4K | - |
| Dec 10, 2025 | Asheet Mehta
Director
|
Grant | 11.4K | - |
| Dec 10, 2025 | Dan Petrozzo
Director
|
Grant | 11.4K | - |
| Dec 10, 2025 | Avi Zeevi
Director
|
Grant | 11.4K | - |
| Dec 2, 2025 | Cory Vieira
Officer
|
Sell | 8.4K | $195.4K |
| Dec 2, 2025 | Cory Vieira
Officer
|
Grant | 20.8K | - |
| Oct 16, 2025 | Sanjiv Das
President
|
Sell | 12.8K | $351.2K |
| Oct 16, 2025 | Sanjiv Das
President
|
Grant | 22.9K | - |
| Oct 13, 2025 | Tami Rosen
Officer and Director
|
Option | 9.4K | $100.0K |
| Oct 1, 2025 | Tami Rosen
Officer and Director
|
Sell | 15.0K | $461.8K |
| Oct 1, 2025 | Evangelos Perros
Chief Financial Officer
|
Sell | 12.8K | $385.2K |
| Oct 1, 2025 | Sanjiv Das
President
|
Sell | 4.8K | $144.4K |
| Oct 1, 2025 | Sanjiv Das
President
|
Grant | 8.5K | - |
| Oct 1, 2025 | Evangelos Perros
Chief Financial Officer
|
Grant | 22.8K | - |
| Sep 15, 2025 | Tami Rosen
Officer and Director
|
Sell | 13.9K | $571.4K |
| Sep 15, 2025 | Sanjiv Das
President
|
Sell | 13.3K | $540.4K |
| Sep 15, 2025 | Evangelos Perros
Chief Financial Officer
|
Sell | 11.6K | $469.3K |
| Sep 15, 2025 | Dan Petrozzo
Director
|
Sell | 2.8K | $117.2K |
| Sep 15, 2025 | Tami Rosen
Officer and Director
|
Option | 21.5K | $62.3K |
| Sep 12, 2025 | Sanjiv Das
President
|
Grant | 23.8K | - |
| Sep 12, 2025 | Evangelos Perros
Chief Financial Officer
|
Grant | 20.6K | - |
| Sep 9, 2025 | Evangelos Perros
Chief Financial Officer
|
Sell | 23.8K | $902.4K |
| Aug 28, 2025 | Sanjiv Das
President
|
Sell | 12.1K | $448.6K |
| Jul 18, 2025 | Dan Petrozzo
Director
|
Sell | 8.5K | $255.8K |
| Jul 17, 2025 | Sanjiv Das
President
|
Sell | 12.7K | $330.7K |
| Jul 16, 2025 | Sanjiv Das
President
|
Grant | 22.9K | - |
| Jul 3, 2025 | Tami Rosen
Officer and Director
|
Sell | 28.5K | $632.6K |
| Jul 2, 2025 | Evangelos Perros
Chief Financial Officer
|
Sell | 12.8K | $287.9K |
| Jul 2, 2025 | Sanjiv Das
President
|
Sell | 4.8K | $108.0K |
| Jul 1, 2025 | Sanjiv Das
President
|
Grant | 8.5K | - |
| Jul 1, 2025 | Evangelos Perros
Chief Financial Officer
|
Grant | 22.8K | - |
| Jul 1, 2025 | Tami Rosen
Officer and Director
|
Grant | 28.5K | - |
| Jun 25, 2025 | Tami Rosen
Officer and Director
|
Sell | 10.0K | $202.4K |
| Jun 12, 2025 | Sanjiv Das
President
|
Sell | 13.6K | $242.6K |
| Jun 12, 2025 | Evangelos Perros
Chief Financial Officer
|
Sell | 11.8K | $210.6K |
| Jun 12, 2025 | Tami Rosen
Officer and Director
|
Sell | 8.2K | $146.5K |
| Jun 12, 2025 | Sanjiv Das
President
|
Grant | 23.8K | - |
| Jun 12, 2025 | Evangelos Perros
Chief Financial Officer
|
Grant | 20.6K | - |
| Jun 12, 2025 | Tami Rosen
Officer and Director
|
Grant | 15.6K | - |
| Jun 10, 2025 | Tami Rosen
Officer and Director
|
Sell | 13.8K | $244.2K |
| Jun 3, 2025 | Sanjiv Das
President
|
Sell | 31.4K | $538.2K |
| May 14, 2025 | Yahav Haim Yulzari
Officer and Director
|
Sell | 20.8K | $314.1K |
| May 13, 2025 | Yahav Haim Yulzari
Officer and Director
|
Sell | 355.7K | $5.4M |
| May 12, 2025 | Avital Pardo
Chief Technology Officer
|
Sell | 116.5K | $1.8M |
Source: TwelveData, from SEC Form 4 filings
PGY stock forecast: questions people ask
Answered from the figures on this page, as of November 6, 2026.